Feedback / Questions
avasopasem (GC4419) - Biossil
OBX-115 - Obsidian, UT MD Anderson Cancer Center
tilarginine (L-NMMA) - Galera Therap
https://www.businesswire.com/news/home/20260414356791/en/Obsidian-Therapeutics-and-Galera-Therapeutics-Announce-Merger-Agreement-and-%24350-Million-Concurrent-Private-Placement
Apr 14, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next